Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Mesothelioma |
| Start Date: | November 1, 1999 |
| Phase: | Phase III |
| Status: | Completed |
| NCT ID: | NCT00005636 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: pemetrexed disodium |
| Study Design: | Allocation: Randomized|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Memorial Sloan-Kettering Cancer Center|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other|NIH |
| First Received: | May 2, 2000 |
| End Date: | |
| Last Updated: | July 23, 2008 |
| Last Verified: | June 1, 2007 |